# Evaluation of the Dosing Regimen of Vancomycin in Pediatric Patients

> **NCT03560440** · — · COMPLETED · sponsor: **Universitaire Ziekenhuizen KU Leuven** · enrollment: 368 (actual)

## Conditions studied

- Gram-Positive Bacterial Infections

## Interventions

- **OTHER:** Plasma exposure vancomycin

## Key facts

- **NCT ID:** NCT03560440
- **Lead sponsor:** Universitaire Ziekenhuizen KU Leuven
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-06
- **Primary completion:** 2016-02
- **Final completion:** 2017-06
- **Target enrollment:** 368 (ACTUAL)
- **Last updated:** 2018-06-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03560440

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03560440, "Evaluation of the Dosing Regimen of Vancomycin in Pediatric Patients". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03560440. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*